Yevgeny Mironer
Interventional Pain Medicine · Spartanburg, SCNPI 1992728141
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Abbott at 46.1% of the total. Reporting peaked in 2023 at $1,451 and has fallen 90.9% since, to $132 in 2025.
Across 196 payments — averaging $29.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Nevro Corp.$867
- Boston Scientific$656
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$304
- Medtronic$202
- Scilex Pharmaceuticals Inc.$184
- plus $872 from 24 others
Across 13 payments — averaging $1228.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- MML US, Inc.$11K
- GRT US Holding, Inc.$5K
- Purdue Pharma L.p.$174
- Hikma Pharmaceuticals USA$174
- Endo Pharmaceuticals Inc.$158
What the payments were for
- Food & beverage$5,64899%
- Education$761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 81 | $2,638 |
| Nevro Corp. | 10 | $867 |
| Boston Scientific | 16 | $656 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $304 |
| Medtronic | 2 | $202 |
| Scilex Pharmaceuticals Inc. | 11 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $146 |
| Forte Bio-pharma LLC | 3 | $136 |
| Fidia Pharma USA Inc. | 5 | $80 |
| GRT US Holding, Inc. | 2 | $60 |
| Arbor Pharmaceuticals, Inc. | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 4 | $53 |
| Pfizer | 3 | $49 |
| Almatica Pharma LLC | 2 | $37 |
| AstraZeneca | 2 | $31 |
| AbbVie | 1 | $22 |
| SPR Therapeutics, Inc | 1 | $20 |
| Si-bone, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Stimwave Technologies Incorporated | 1 | $14 |
| Novartis | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Nalu Medical, Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $14 |
| Zimmer Biomet | 1 | $13 |
| Shionogi Inc | 1 | $13 |
| Virtus Pharmaceuticals LLC | 1 | $11 |
| MDD US Operations, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$636
- Proclaim IPG$412
- Octrode SCS Leads$176
- PROCLAIM$142
- ETERNA$132
- Proclaim Family of SCS IPGs$131
- Protege Family of SCS IPGs$103
How this compares
$5,723 in reported general payments places this provider in the 65th percentile of 38 interventional pain medicine providers in South Carolina.
See all interventional pain medicine providers in South Carolina →
Other interventional pain medicine in Spartanburg
- Joshua BighamSpartanburg$14K
- John HaasisSpartanburg$4K
- Nisarg PatelSpartanburg$3K
- Jeffrey SmithSpartanburg$2K
- Mark NethertonMt Pleasant$102K
- Marion McMillanSeneca$89K
- Jason RosenbergMurrells Inlet$82K
- Ryan NoblesMt Pleasant$43K
- Justin HutchesonGreenville$23K
- David RoweBluffton$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.